Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 10—October 2017
Dispatch

Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015

Takaaki Tanaka, Tomohiro OishiComments to Author , Ippei Miyata, Shoko Wakabayashi, Mina Kono, Sahoko Ono, Atsushi Kato, Yoko Fukuda, Aki Saito, Eisuke Kondo, Hideto Teranishi, Yuhei Tanaka, Tokio Wakabayashi, Hiroto Akaike, Satoko Ogita, Naoki Ohno, Takashi Nakano, Kihei Terada, and Kazunobu Ouchi
Author affiliations: Kawasaki Medical School, Okayama, Japan

Main Article

Table 2

Rates of macrolide-resistant Mycoplasma pneumoniae and point mutations in domain V of 23S rRNA, Japan

Variable 2008 2009 2010 2011 2012 2013 2014 2015 Total
Macrolide resistance, % (no. positive/total no. patients)
55.6 (10/18)
72.7 (8/11)
69.0 (80/116)
65.8 (319/485)
81.6 (493/604)
65.8 (25/38)
59.3 (16/27)
43.6 (65/149)
70.2 (1,016/
1,448)
Point mutations, no. (%)
A2063G 10 (100) 8 (100) 80 (100) 301 (94.4) 471 (95.5) 25 (100) 16 (100) 62 (95.2) 97.3 (95.8)
A2063C 0 0 0 3 (0.9) 0 0 0 0 3 (0.3)
A2063T 0 0 0 15 (4.7) 14 (2.3) 0 0 2(3.2) 31 (3.1)
A2064G 0 0 0 0 6 (1.0) 0 0 0 6 (0.6)
C2617G 0 0 0 0 2 (0.3) 0 0 0 2 (0.2)
C2617T 0 0 0 0 0 0 0 1 (1.6) 1 (0.1)

Main Article

No table matches the in-text citation "Table 1". Please supply the missing table or delete the citation.

Page created: September 18, 2017
Page updated: September 18, 2017
Page reviewed: September 18, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external